Evidence map›Paper›PMID 37193602›Full record

ArticleeNeuro2023

β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats.

Noah B Walker, Yijin Yan, Melissa A Tapia, Brenton R Tucker, Leanne N Thomas, Brianna E George, Alyssa M West, Christopher B Marotta, Henry A Lester, Dennis A Dougherty and 3 more

Open access · goldAbstract read
In one paragraph

Article in eNeuro, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. "Unraveling the role ofReceptors (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Noah B WalkerDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Yijin YanDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Melissa A TapiaDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Brenton R TuckerDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Leanne N ThomasDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Brianna E GeorgeDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Alyssa M WestDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Christopher B MarottaDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91106.
Henry A LesterDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91106.ORCID 0000-0002-5470-5255
Dennis A DoughertyDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91106.
Katherine M HolleranDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.
Sara R JonesDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157.ORCID 0000-0002-3424-7576
Ryan M DrenanDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157 rdrenan@wakehealth.edu.ORCID 0000-0002-8141-8577
Wake Forest University · USCalifornia Institute of Technology · US

Funding

Identifying nicotine withdrawal mechanisms hidden within habenular complexityR01DA040626 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ryan Michael Drenan · 2016 to 2026
$4.0M
The Neurobiology of Drug AbuseT32DA041349 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SARA RAULERSON JONES · 2017 to 2026
$1.8M
A Longitudinal Mentoring Approach to Increase Diversity-RenewalR25NS117356 · NINDS · UNIVERSITY OF MINNESOTA · PI Angeline Joan Dukes, Paul G Mermelstein · 2020 to 2026
$1.6M
Dopamine D3 Receptors as a Potential Therapeutic Target for Heroin AbuseF31DA049504 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GEORGE, BRIANNA ELYSE · 2019 to 2021
$134k
NIDA NIH HHS F31 DA049504NIDA NIH HHS R01 DA040626NIDA NIH HHS T32 DA041349NINDS NIH HHS R25 NS117356
6 · The paper itself

Abstract

Mesolimbic nicotinic acetylcholine receptor (nAChRs) activation is necessary for nicotine reinforcement behavior, but it is unknown whether selective activation of nAChRs in the dopamine (DA) reward pathway is sufficient to support nicotine reinforcement. In this study, we tested the hypothesis that activation of β2-containing (β2*) nAChRs on VTA neurons is sufficient for intravenous nicotine self-administration (SA). We expressed β2 nAChR subunits with enhanced sensitivity to nicotine (referred to as β2Leu9'Ser) in the VTA of male Sprague Dawley (SD) rats, enabling very low concentrations of nicotine to selectively activate β2* nAChRs on transduced neurons. Rats expressing β2Leu9'Ser subunits acquired nicotine SA at 1.5 μg/kg/infusion, a dose too low to support acquisition in control rats. Saline substitution extinguished responding for 1.5 μg/kg/inf, verifying that this dose was reinforcing. β2Leu9'Ser nAChRs also supported acquisition at the typical training dose in rats (30 μg/kg/inf) and reducing the dose to 1.5 μg/kg/inf caused a significant increase in the rate of nicotine SA. Viral expression of β2Leu9'Ser subunits only in VTA DA neurons (via TH-Cre rats) also enabled acquisition of nicotine SA at 1.5 μg/kg/inf, and saline substitution significantly attenuated responding. Next, we examined electrically-evoked DA release in slices from β2Leu9'Ser rats with a history of nicotine SA. Single-pulse evoked DA release and DA uptake rate were reduced in β2Leu9'Ser NAc slices, but relative increases in DA following a train of stimuli were preserved. These results are the first to report that β2* nAChR activation on VTA neurons is sufficient for nicotine reinforcement in rats.

Indexed as

NicotineReceptors, NicotinicAnimalsDopaminergic NeuronsMaleNicotinic AgonistsRatsRats, Sprague-DawleyVentral Tegmental AreaNicotineNicotinic AgonistsReceptors, Nicotinicacetylcholineaddictiondopaminenicotinereinforcementtobacco

Identifiers

PMID37193602
PMCPMC10216253
OpenAlexW4376871417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.